Clinical trial
A Multicenter, Randomized Controlled, Non-inferiority Trial Investigating Efficacy and Safety of Pulmonary Vein Isolation Alone for Recurrence Prevention Compared to Extensive Ablation in Patients With Persistent Atrial Fibrillation
NCT03514693 is registered in ClinicalTrials.gov with Osaka Cardiovascular Conference as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized Controlled, Non-inferiority Trial Investigating Efficacy and Safety of Pulmonary Vein Isolation Alone for Recurrence Prevention Compared to Extensive Ablation in Patients With Persistent Atrial Fibrillation
- Lead sponsor
- Osaka Cardiovascular Conference
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 2, 2016
- Completion date
- March 31, 2019
- Enrollment
- 512 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, catheter ablation, recurrence